Browse studies

Find your next paid study

6 recruiting studies matching your filters

A Phase 3, Single-Arm, Open-Label, Long-Term Extension Study To Evaluate The Safety And Efficacy Of Enpatoran In Participants With Active Cutaneous Manifestations Of Lupus Erythematosus With Or Without Systemic Disease Receiving Standard Of Care [Elowen-LTE]

The purpose of this study is to evaluate the long-term safety and efficacy of orally administered enpatoran in participants with cutaneous manifestations of lu…

Systemic Lupus Erythematosus (SLE)Cutaneous Lupus Erythematosus (CLE)

Estimated

~$10 – $8,750

EMD Serono Research & Development Institute, Inc.NCT07840287

Phase 3

A Phase 3, Randomized, Double-Blind,Placebo-Controlled Parallel Study to Evaluate the Efficacy and Safety of Enpatoran in Participants With Active Cutaneous Manifestations of Lupus Erythematosus With or Without Systemic Disease Receiving Standard of Care (ELOWEN-1)

The purpose of this global, multicenter, Phase 3 study is to evaluate the efficacy and safety of enpatoran over 24 weeks in participants with active cutaneous …

Systemic Lupus Erythematosus (SLE)Cutaneous Lupus Erythematosus (CLE)

Estimated

~$10 – $8,750

EMD Serono Research & Development Institute, Inc.NCT07332481

Phase 2

A Randomized, Double-blind, Placebo-controlled Study of Quinacrine (QC) in Participants With Active Cutaneous Lupus Erythematosus (CLE), Including Subacute CLE (SCLE) and/or Discoid LE (DLE), With or Without Concurrent Systemic Manifestations

The research study is being conducted to learn more about how patients with cutaneous lupus erythematosus (CLE) respond to the use of quinacrine. Quinacrine is…

Cutaneous Lupus Erythematosus (CLE)

Estimated

~$10 – $7,500

Victoria WerthNCT07694336

Phase 2

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus

The goal of this clinical trial is to learn if VENT-03 works to treat patients with cutaneous lupus erythematosus (CLE) who may or may not have systemic lupus …

Cutaneous Lupus Erythematosus (CLE)Systemic Lupus ErythematosusSLE+2 more

Estimated

~$10 – $8,750

Ventus Therapeutics U.S., Inc.NCT07260877

Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus

The Cutaneous Lupus Erythematosus (CLE) database, established in 2006, is a multi-site database between the University of Pennsylvania and the University of Te…

Cutaneous Lupus Erythematosus (CLE)

Estimated

~$10 – $750

University of PennsylvaniaNCT01510067

Web-Based Data Collection Through the Research Accelerated by You (RAY) Lupus Registry

Summary The Lupus Foundation of America (LFA) Research Accelerated by You (RAY) Registry is a fully remote, longitudinal registry designed to collect data from…

Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)Cutaneous Lupus Erythematosus (CLE)

Estimated

~$10 – $750

Lupus Foundation of AmericaNCT06927219